COCP CIK: 1412486

Cocrystal Pharma, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
0
FY23:
0
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−14.2
FY22:
−38.8
FY23:
−18.6
FY24:
−17.9
FY25:
−9.02
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.8
FY22:
–
FY23:
–
FY24:
−17.3
FY25:
−8.70
(positive)
Change from FY21 to FY25
millions USD
FY21:
−14.2
FY22:
–
FY23:
–
FY24:
−18.6
FY25:
−8.83
(positive)
Change from FY21 to FY25
millions USD
FY21:
−14.2
FY22:
−38.8
FY23:
−18.0
FY24:
−17.5
FY25:
−8.83

All amounts in millions USD Data sources:SEC EDGARTwelve Data